Literature DB >> 6611254

Modulation of the cytosolic androgen receptor in striated muscle by sex steroids.

N E Rance, S R Max.   

Abstract

We studied the influence of orchiectomy (GDX) and steroid administration on the level of cytosolic androgen receptor in rat levator ani muscle and rat skeletal muscles (tibialis anterior and extensor digitorum longus). Androgen receptor binding to muscle cytosol was measured using [3H]methyltrienolone (R1881) as ligand, a 100-fold molar excess of unlabeled R1881 to assess nonspecific binding, and a 500-fold molar excess of triamcinolone acetonide to prevent binding to glucocorticoid and progestin receptors. Bound and free ligand were separated by column chromatography with Sephadex G-75. In levator ani muscles from intact animals (controls), maximum R1881 binding (Bmax), determined by Scatchard analysis, was 2.5 fmol/mg protein (Kd = 0.68 nM). Thirty days after GDX, Bmax increased to 500% of the control value, with no significant change in Kd (0.96 nM). Using saturating levels of R1881, Bmax was increased to 280% of the control value 12 h post-GDX, 600% at 14 days, 478% at 30 days, and 133% at 44 days. The increase in receptor binding was blocked by cycloheximide. Administration of Silastic capsules containing testosterone propionate 30 days post-GDX resulted in R1881 binding at the control level at 44 days. Surprisingly, administration of 17 beta-estradiol (E2) 30 days post-GDX resulted in increased (480%) R1881 binding. Thus, E2 may cause induction of the cytosolic androgen receptor in levator ani muscle from GDX rats; alternatively, the rate of receptor degradation may be altered. R1881 binding by skeletal muscle cytosol was increased 139% at 12 h, 212% on day 14, 220% on day 30, and 158% on day 44 with respect to the control value. Administration of testosterone propionate at 30 days caused R1881 binding to return to the control value by day 44, whereas E2 was without influence. The differences in response of levator ani and skeletal muscle receptors may account for the differential effects of sex steroids on these muscle types.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6611254     DOI: 10.1210/endo-115-3-862

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  6 in total

Review 1.  Body composition and muscle performance during menopause and hormone replacement therapy.

Authors:  S Sipilä
Journal:  J Endocrinol Invest       Date:  2003-09       Impact factor: 4.256

2.  Secretagogue type, sex-steroid milieu, and abdominal visceral adiposity individually determine secretagogue-stimulated cortisol secretion.

Authors:  Ali Iranmanesh; Cyril Y Bowers; Johannes D Veldhuis
Journal:  Eur J Endocrinol       Date:  2010-03-18       Impact factor: 6.664

Review 3.  Age-dependent and gender-dependent regulation of hypothalamic-adrenocorticotropic-adrenal axis.

Authors:  Johannes D Veldhuis; Animesh Sharma; Ferdinand Roelfsema
Journal:  Endocrinol Metab Clin North Am       Date:  2013-03-13       Impact factor: 4.741

Review 4.  Pharmacology of anabolic steroids.

Authors:  A T Kicman
Journal:  Br J Pharmacol       Date:  2008-06       Impact factor: 8.739

5.  Mitochondrial function in diaphragm of emphysematous hamsters after treatment with nandrolone.

Authors:  Hanneke J H Wijnhoven; Leo Ennen; Richard J T Rodenburg; P N Richard Dekhuijzen
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006

6.  Catechol-o-methyltransferase gene polymorphism is associated with skeletal muscle properties in older women alone and together with physical activity.

Authors:  Paula H A Ronkainen; Eija Pöllänen; Timo Törmäkangas; Kristina Tiainen; Markku Koskenvuo; Jaakko Kaprio; Taina Rantanen; Sarianna Sipilä; Vuokko Kovanen
Journal:  PLoS One       Date:  2008-03-19       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.